CH
抗体药类似物
Research Grade Camidanlumab
All
  • CatalogTD-HF996036
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsADCT-301(unconjugated),HuMax-TAC-ADC,CAS:921618-45-3
  • Specification
    1mg
  • Prices
    ¥询价
Customized service consulting

Research Grade Camidanlumab


Catalog No. TD-HF996036
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target IL2-RA, IL-2R subunit alpha, TAC antigen, IL-2-RA, p55, IL2RA, IL-2 receptor subunit alpha, Interleukin-2 receptor subunit alpha, CD25
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P01589
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names ADCT-301(unconjugated),HuMax-TAC-ADC,CAS:921618-45-3
Background Camidanlumab (HuMax-TAC) is a CD25 monoclonal antibody. Camidanlumab targets the cell-surface antigen CD25, which is over-expressed on a variety of hematological tumors and shows limited expression on normal tissues. Camidanlumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including lymphoma and leukemia.
Note For research use only. Not for use in clinical or therapeutic applications.